Do stomach acid, intrinsic factor, and small-intestinal uptake determine vitamin B12 and folate status?

Based on a robust body of clinical and physiological evidence, the mechanisms underlying the absorption and systemic utilization of vitamin B12 and folate are highly dependent on gastric acidity, specialized binding proteins, localized intestinal transporters, and a balanced microbiome.

Clinical and physiological evidence

• Vitamin B12 absorption: Active B12 (cobalamin) assimilation is a multi-step, sequential process. It requires gastric acid and pepsin to cleave B12 from dietary proteins, secretable intrinsic factor (IF) from gastric parietal cells to form a protective IF-B12 complex, and expression of the cubam receptor complex (cubilin and amnionless) in the terminal ileum to mediate calcium-dependent endocytosis. The active pathway is highly saturable, with a physiological limit of approximately 1 to 1.5 µg per oral dose.
• Folate absorption: Dietary folate absorption is localized primarily to the proximal small intestine (duodenum and proximal jejunum). This is driven by the proton-coupled folate transporter (PCFT; SLC46A1), an electrogenic proton symporter operating at the apical brush-border membrane of enterocytes. The reduced folate carrier (RFC; SLC19A1) plays a secondary, auxiliary role under physiological conditions.

Mechanistic pathways and dysbiosis

• Hypochlorhydria: A reduction in stomach acid (common with aging, atrophic gastritis, or proton pump inhibitors) impairs the liberation of food-bound cobalamin. Furthermore, hypochlorhydria compromises the gastric acid barrier, facilitating oral and ingested bacteria to survive and colonize the small intestine, leading to Small Intestinal Bacterial Overgrowth (SIBO).
• Bacterial consumption and the "folate trap": In cases of SIBO-related dysbiosis, overgrowth bacteria actively consume luminal B12 and synthesize inactive analogues that compete for ileal cubam receptors. While SIBO can paradoxically raise serum folate due to bacterial synthesis, the co-occurring B12 deficiency can trigger a functional "folate trap" (impairing the conversion of 5-methyltetrahydrofolate), while local mucosal damage can cause direct folate malabsorption.
• Dietary intake: Because humans cannot synthesize B12 or folate de novo, reduced dietary intake directly lowers baseline status, a risk that is significantly compounded when digestive or absorptive pathways are compromised.

Bottom line

Vitamin B12 and folate status rely on a highly coordinated digestive chain. Hypochlorhydria, dysbiosis (like SIBO), and low dietary intake represent interactive mechanisms that impair the liberation, transport, and metabolic utilization of these essential vitamins, directly driving clinical and subclinical deficiency states.